BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Saturday, June 6, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 25, 2007
View Archived Issues
Almirall acquires Hermal skincare business from Reckitt Benckiser
Read More
Profectus receives grant to develop anti-HIV antibodies
Read More
Taxus Element Stent begins new program
Read More
New antiinfective drugs disclosed in recent patent literature
Read More
New treatment options for neurological diseases claimed in recent patents
Read More
EpiCept NP-1 enters phase IIb and phase III studies for multiple indications
Read More
Schering-Plough announces acadesine licensing for cardiac surgery complications
Read More
Forbes Medi-Tech on track for corporate objectives and revenue growth
Read More
GW Pharmaceuticals's E.U. regulatory withdrawal
Read More
Meda enters U.S. market through strategic acquisition of MedPointe
Read More
Elan and Biogen Idec will appeal ruling on European application for natalizumab
Read More
FDA allows IND for Cougar Biotechnology's noscapine
Read More
Results from Samaritan's phase IIb study of novel HIV entry inhibitor
Read More
Tercica completes clinical trial enrollment for Increlex in pediatric primary IGFD
Read More
Phase I study to examine the safety and anticancer efficacy of the novel TCR/IL-2 fusion protein
Read More
Sygnis' phase IIa study of AX-200 for stroke completed
Read More
Ark withdraws EMEA early marketing approval application of Cerepro
Read More
FDA accepts QLT's labeling sNDA for Aczone
Read More
FDA grants permission to Kinex to proceed to phase I trials of KX2-391
Read More
Novel HCV NS5B polymerase inhibitors emerge from Pfizer R&D
Read More
Advisory committee recommendation for Evista in breast cancer risk reduction
Read More
Preliminary clinical safety of the recombinant gag-env HIV-1 protein-based vaccine VICHREPOL shown
Read More
Wyeth receives approvable letter for Pristiq in menopause-related vasomotor symptoms
Read More
CCR5 antagonist INCB-009471 exerts potent, prolonged antiretroviral activity in HIV patients
Read More
PF-429242: Example of novel S1P inhibitors for dyslipidemia and related disorders
Read More
